The Course of an Autosomal Dominant Polycystic Kidney Disease: Rare Association with Waldenström Macroglobulinemia and other Co-occurrences

Autores

  • Isabel Marques Correia Serviço de Medicina Interna, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal
  • Isabel Fonseca Serviço de Medicina Interna, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal. Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal

DOI:

https://doi.org/10.60591/crspmi.336

Palavras-chave:

Polycystic Kidney, Autosomal Dominant, Polycystic Liver Disease, Waldenström Macroglobulinemia

Resumo

We present a case of a 50-year-old female, known to have a history of autosomal dominant polycystic kidney disease (ADPKD) and controlled hypertension, who was referred for polycystic liver. Her family history is remarkable for her father, who received a renal transplant in the setting of ADPKD. The patient remained under regular follow-up with normal renal and hepatic function. She developed recurrent episodes of pain in the upper abdomen, malnutrition and cyst infection. At this point, she had signs of hepatic venous outflow obstruction and imaging showed massive liver enlargement. The patient was proposed for a liver transplant. A decade after ADPKD was identified, she had been diagnosed with Waldenström macroglobulinemia (WM). Hematological malignancies have rarely been described in coexistence with ADPKD. There is one such reported case with multiple myeloma. However, in our search, we have not found any case of ADPKD-associated WM. This association should prompt thorough and frequent monitoring.

Downloads

Não há dados estatísticos.

Referências

Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393:919-35. doi:10.1016/S0140-6736(18)32782-X

Colbert GB, Elrggal ME, Gaur L, Lerma E V. Update and review of adult polycystic kidney disease. Disease-a-Month. 2020;66:100887. doi:10.1016/j.disamonth.2019.100887

Mochizuki T, Makabe S, Aoyama Y, Kataoka H, Nitta K. New Insights into Cystic Kidney Diseases. Contrib Nephrol. 2018;195:31-41. doi:10.1159/000486932

Zhang ZY, Wang ZM, Huang Y. Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management. World J Hepatol. 2020;12:72-83. doi:10.4254/wjh.v12.i3.72

Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nat Rev Dis Prim. 2018;4. doi:10.1038/s41572-018-0047-y

van Aerts RMM, van de Laarschot LFM, Banales JM, Drenth JPH. Clinical management of polycystic liver disease. J Hepatol. 2018;68:827-37. doi:10.1016/j.jhep.2017.11.024

Uppal NN, Monga D, Vernace MA, et al. Kidney diseases associated with Waldenström macroglobulinemia. Nephrol Dial Transplant. 2019;34:1644-52. doi:10.1093/ndt/gfy320

Gertz MA. Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management. Am J Hematol. 2023;98:348-58. doi:10.1002/ajh.26796

Kaseb H, Gonzalez-Mosquera L, Parsi M, Mewawalla P. Lymphoplasmacytic Lymphoma. Treasure Island: StatPearls Publishing; 2025.

Park M, Lee SK, Choi J, et al. Differentiation between cystic pituitary adenomas and rathke cleft cysts: A diagnostic model using mri. Am J Neuroradiol. 2015;36:1866-73. doi:10.3174/ajnr.A4387

Mangaraj S, Patro D, Choudhury AK, Baliarsinha AK. A Rare Case of Acromegaly and Autosomal Dominant Polycystic Kidney Disease: Case Report and Brief Review of Literature. AACE Clin Case Rep. 2019;5:e302-6. doi:10.4158/ACCR-2019-0128

Norcia LF, Watanabe EM, Hamamoto Filho PT, et al. Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment. Hepatic Med Evid Res. 2022;14:135-61. doi:10.2147/hmer.s377530

Morii K, Yamamoto T, Nakamura S, Okushin H. Infectious hepatic cyst: An underestimated complication. Intern Med. 2018;57:2123-9. doi:10.2169/internalmedicine.0511-17

Schellekens P, Van Loon E, Coemans M, et al. Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up. Clin Kidney J.2023;16:2578-86. doi:10.1093/ckj/sfad165

Schellekens P, Roosens W, Meyts I, Vennekens R, Bammens B, Mekahli D. Cytopenia in autosomal dominant polycystic kidney disease (ADPKD): merely an association or a disease-related feature with prognostic implications Pediatr Nephrol. 2021;36:3505-14. doi:10.1007/s00467-021-04937-9

Sumida K, Ubara Y, Takaichi K, Wake A. Primary effusion lymphoma-like lymphoma with polycystic kidney disease. BMJ Case Rep. 2012:2011-12. doi:10.1136/bcr-02-2012-5774 17. Mandal SK, Ganguly J, Mondal SS, Sil K. An unusual association of autosomal polycystic kidney disease and multiple myeloma. BMJ Case Rep. 2014;2014. doi:10.1136/bcr-2013-201637

Downloads

Publicado

28-03-2025

Como Citar

Marques Correia, I., & Fonseca, I. (2025). The Course of an Autosomal Dominant Polycystic Kidney Disease: Rare Association with Waldenström Macroglobulinemia and other Co-occurrences. SPMI Case Reports, 3(1), 26–30. https://doi.org/10.60591/crspmi.336

Edição

Secção

Casos Clínicos

Categorias

Artigos mais lidos do(s) mesmo(s) autor(es)